| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 319.38B | 315.98B | 276.32B | 284.60B | 256.84B |
| Gross Profit | 81.46B | 77.41B | 59.23B | 61.11B | 63.36B |
| EBITDA | 42.34B | 41.92B | 26.53B | 28.69B | 34.68B |
| Net Income | 17.38B | 14.48B | 5.24B | 11.51B | 16.64B |
Balance Sheet | |||||
| Total Assets | 342.73B | 340.47B | 333.59B | 304.88B | 302.87B |
| Cash, Cash Equivalents and Short-Term Investments | 60.27B | 55.51B | 55.49B | 38.03B | 55.42B |
| Total Debt | 7.52B | 12.74B | 14.51B | 2.56B | 4.11B |
| Total Liabilities | 84.48B | 94.34B | 100.67B | 77.73B | 93.11B |
| Stockholders Equity | 257.48B | 245.37B | 232.22B | 226.44B | 209.31B |
Cash Flow | |||||
| Free Cash Flow | 18.76B | 9.95B | 24.77B | -6.61B | 16.12B |
| Operating Cash Flow | 33.45B | 33.72B | 39.20B | 5.94B | 24.64B |
| Investing Cash Flow | -14.59B | -24.67B | -21.51B | -12.14B | -19.64B |
| Financing Cash Flow | -15.60B | -12.33B | -1.29B | -12.78B | -14.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥350.99B | 16.94 | 5.12% | 2.36% | 1.08% | 25.31% | |
67 Neutral | ¥161.40B | 12.48 | 3.57% | 1.31% | 0.86% | 158.75% | |
66 Neutral | ¥8.34B | 8.02 | ― | 1.90% | 3.25% | 32.39% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥798.99B | 13.87 | 2.55% | 3.51% | 0.67% | 31.73% | |
55 Neutral | ¥45.96B | 19.03 | -0.13% | 2.31% | -10.51% | -56.26% | |
49 Neutral | ¥156.57B | 19.04 | 1.66% | 1.53% | -1.57% | ― |